Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, October 21, 2014
 
Register | Sign in
Home Page>Products
  Product News
Bioo Scientific Improves Sensitivity and Reliability of Tetracycline Detection
Tuesday, September 30, 2014
New MaxSignal® Tetracycline ELISA Kit with ready-to-use standards.

Almac Doubles Global 2-8°C Cold Room Capacity
Tuesday, September 30, 2014
Dedicated temperature and humidity controlled labelling suites go live in USA and Europe as business from biosimilars and biologics clinical studies expands.

HEPA-lite set to open doors for GMP packaging manufacturing
Friday, September 26, 2014
A unique new product is set to minimise the costs associated with packaging production to GMP air standards.

New CombiCult® Technology Massively Accelerates Development of Stem Cell Cures
Friday, September 26, 2014
CombiCult® technology enables a single scientist to carry out 10,000 stem cell biology experiments in parallel.

A New Solid-State Platform for High-Throughput ChIP
Thursday, September 25, 2014
Porvair’s new technical article provides an introduction to Chromatrap® 96.

Mobidiag Announces CE-IVD Marking of Amplidiag™ Bacterial GE
Thursday, September 25, 2014
Test optimizes screening of gastroenteritis-causing bacteria directly from stool samples.

Western Blotting Transformed by GE Healthcare Life Sciences
Thursday, September 25, 2014
New Amersham™ WB system for reproducible and quantitative protein analysis.

EPIC Research Tool for Ultra-High Vacuum
Thursday, September 25, 2014
New EPIC quadrupole mass spectrometer from Hiden.

Gas Bubblers Ensure Maintenance of Inert Reaction Atmospheres
Wednesday, September 24, 2014
New range of gas bubblers from Asynt provide a one-way valve.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 10580
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv